Skip to main content
OpenTrials
Completed

NCT Number: NCT03118973

Evaluation of Efficacy and Safety of Goff Transpancreatic Septotomy vs. Double Wire Technique for Achieving Biliary Access in Technically Challenging ERCPs

Randomized, prospective study evaluating efficacy and safety of Goff transpancreatic septotomy vs. double wire technique for achieving biliary access in patients who fail initial cannulation at ERCP.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Stanford University School of Medicine

Stanford, California, 94305, United States

About this study

Selective placement of a guidewire into the bile duct (biliary cannulation) during endoscopic retrograde cholangiopancreatography (ERCP) is necessary for performing therapeutic biliary procedures. The success rate for biliary cannulation by experienced endoscopists during ERCP is approximately 85% with standard cannulation techniques. Inadvertent placement of the guidewire into the pancreatic duct rather than the bile duct often occurs when attempting selective biliary cannulation in technically challenging cases. When this occurs repeatedly, other approaches may be used to facilitate selective biliary cannulation, but there are few prospective studies evaluating the efficacy and safety of these approaches. Here the investigators evaluate two approaches for technically challenging biliary cannulation: one involving maintenance of a wire in the pancreatic duct, followed by repeat attempt at biliary cannulation (double wire technique) and one involving a small incision in the septum adjacent to the pancreas followed by repeat attempt at biliary cannulation (transpancreatic septotomy). This study is a prospective randomized trial comparing the rate of cannulation success, procedure duration and complications following these two approaches.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 and older
  • Patient has a clinical indication for ERCP
  • Willing and able to comply with the study procedures and provide written informed consent to participate in the study.

Exclusion criteria

  • Age <18
  • Potentially vulnerable subjects including, homeless people, pregnant females, employees and students.
  • Complex post-surgical anatomy e.g. Billroth type II anatomy, Roux-en-Y-gastrojejunostomy
  • Prior sphincterotomy or balloon dilation of ampulla
  • Thrombocytopenia, coagulopathy, or indication for ongoing anti-coagulation therapy
  • Participation in another investigational study that may directly or indirectly affect the results of this study within 30 days prior to the initial visit

Treatment and study plan

Goff trans-pancreatic septotomy vs. Double wire technique

Procedure

Goff trans-pancreatic septotomy vs. Double wire technique for achieving biliary access when biliary cannulation is challenging.

Primary outcomes

  1. Successful biliary cannulation assessed by fluoroscopic confirmation of biliary cannulation

    Time frame: Day of procedure

    Successful biliary cannulation

Secondary outcomes

  1. Adverse event rates assessed by 6-month follow-up of clinical and laboratory studies

    Time frame: 6 months

    Rates of adverse events associated with the ERCP procedure following intervention to facilitate biliary cannulation.

Sponsors and collaborators

Lead sponsor

Subhas Banerjee

Other

Registry information

Important dates

Study start
2016
Primary completion
2020
Study completion
2020
First posted
Apr 18, 2017
Registry last updated
Nov 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.